Natural History Study of Oculopharyngeal Muscular Dystrophy
NCT03161847 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-05-27
Summary
The objective of this study is to test a set of clinical outcome measures longitudinally in a cohort of OPMD patients to identify ones that show quantifiable change over time as the disease progresses. The investigators' goal is to delineate the natural history of OPMD.
Conditions
- Oculopharyngeal Muscular Dystrophy
Interventions
- OTHER
-
Non-interventional study
Non-interventional study
Sponsors & Collaborators
-
University of Florida
collaborator OTHER -
University of New Mexico
lead OTHER
Principal Investigators
-
Sarah Youssof, MD, MS · New Mexico Neuromuscular Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-12
- Primary Completion
- 2018-07-18
- Completion
- 2018-07-18
More Related Trials
-
Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study
NCT02780492 ·Status: COMPLETED
-
Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
NCT00004685 ·Status: COMPLETED ·Phase: NA
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-
NCT02708784 ·Status: UNKNOWN
-
Natural History Study of Mitochondrial Myopathy
NCT05250375 ·Status: RECRUITING
-
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
NCT01753804 ·Status: TERMINATED
-
Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.
NCT01990976 ·Status: COMPLETED
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
NCT00027391 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00004646 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
NCT06321965 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS
NCT03334786 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT06547216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy
NCT05812144 ·Status: COMPLETED ·Phase: NA
-
1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy
NCT02159612 ·Status: COMPLETED
-
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
NCT02195999 ·Status: COMPLETED
-
Clinical Outcome Measures in Myotonic Dystrophy Type 2
NCT03603171 ·Status: COMPLETED
-
Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
NCT06227182 ·Status: RECRUITING
-
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarkers in Friedreich's Ataxia
NCT02497534 ·Status: RECRUITING
-
A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren
NCT03796637 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy
NCT06517498 ·Status: RECRUITING
-
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
NCT02310763 ·Status: TERMINATED ·Phase: PHASE2